Developing a Nonendoscopic Screening Test for Barrett‘s Esophagus

• Ferlay J , ShinHR, BrayFet al. : Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.Int. J. Cancer127(12), 2893–2917 (2010).
   PubMed Web of Science ®Google Scholar
• Pohl H , SirovichB, WelchHG: Esophageal adenocarcinoma incidence: are we reaching the peak?Cancer Epidemiol. Biomarkers Prev.19(6), 1468–1470 (2010).
   PubMed Web of Science ®Google Scholar
• Crew KD , NeugutAI: Epidemiology of upper gastrointestinal malignancies.Semin. Oncol.31(4), 450–464 (2004).
   PubMed Web of Science ®Google Scholar
• Nguyen AM , LukeCG, RoderD: Comparative epidemiological characteristics of oesophageal adenocarcinoma and other cancers of the oesophagus and gastric cardia.Asian Pac. J. Cancer Prev.4(3), 225–231 (2003).
   PubMedGoogle Scholar
• van Blankenstein M , LoomanCW, HopWC, BytzerP: The incidence of adenocarcinoma and squamous cell carcinoma of the esophagus: Barrett‘s esophagus makes a difference.Am. J. Gastroenterol.100(4), 766–774 (2005).
   PubMed Web of Science ®Google Scholar
• Younes M , HensonDE, ErtanA, MillerCC: Incidence and survival trends of esophageal carcinoma in the United States: racial and gender differences by histological type.Scand. J. Gastroenterol.37(12), 1359–1365 (2002).
   PubMed Web of Science ®Google Scholar
• Vizcaino AP , MorenoV, LambertR, ParkinDM: Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973–1995.Int. J. Cancer99(6), 860–868 (2002).
   PubMed Web of Science ®Google Scholar
• Sihvo EI , LuostarinenME, SaloJA: Fate of patients with adenocarcinoma of the esophagus and the esophagogastric junction: a population-based analysis.Am. J. Gastroenterol.99(3), 419–424 (2004).
   PubMed Web of Science ®Google Scholar
• Bowrey DJ , GriffinSM, WaymanJet al. : Use of alarm symptoms to select dyspeptics for endoscopy causes patients with curable esophagogastric cancer to be overlooked.Surg. Endosc.20(11), 1725–1728 (2006).
   PubMed Web of Science ®Google Scholar
• Enzinger PC , MayerRJ: Esophageal cancer.N. Engl. J. Med.349(23), 2241–2252 (2003).
   PubMed Web of Science ®Google Scholar
• Medical Research Council Oesophageal Cancer Working Group: Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet359(9319), 1727–1733 (2002).
   PubMed Web of Science ®Google Scholar
• Reid BJ , LiX, GalipeauPC Vaughan TL: Barrett‘s oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat. Rev. Cancer10(2), 87–101 (2010).
   PubMed Web of Science ®Google Scholar
• Pohl H , WelchHG: The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence.J. Natl Cancer Inst.97(2), 142–146 (2005).
   PubMed Web of Science ®Google Scholar
• Peters JH , ClarkGW, IrelandAPet al. : Outcome of adenocarcinoma arising in Barrett‘s esophagus in endoscopically surveyed and nonsurveyed patients.J. Thorac. Cardiovasc. Surg.108(5), 813–821 (1994).
   PubMed Web of Science ®Google Scholar
• Corley DA , LevinTR, HabelLA, WeissNS, BufflerPA: Surveillance and survival in Barrett‘s adenocarcinomas: a population-based study.Gastroenterology122(3), 633–640 (2002).
   PubMed Web of Science ®Google Scholar
• Wilson JM and Jungner YG: [Principles and practice of mass screening for disease]. Bol. Oficina Sanit. Panam.65(4), 281–393 (1968).
   PubMedGoogle Scholar
• Playford RJ : New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett‘s oesophagus.Gut55(4), 442 (2006).
   PubMed Web of Science ®Google Scholar
• Spechler SJ , SharmaP, SouzaRF, InadomiJM, ShaheenNJ: American Gastroenterological Association medical position statement on the management of Barrett‘s esophagus.Gastroenterology140(3), 1084–1091 (2011).
   PubMed Web of Science ®Google Scholar
• Spechler SJ , SharmaP, SouzaRF, InadomiJM, ShaheenNJ: American Gastroenterological Association technical review on the management of Barrett‘s esophagus.Gastroenterology140(3), E18–E52; quiz e13 (2011).
   PubMed Web of Science ®Google Scholar
• Sikkema M , de Jonge PJ, Steyerberg EW, Kuipers EJ: Risk of esophageal adenocarcinoma and mortality in patients with Barrett‘s esophagus: a systematic review and meta-analysis. Clin. Gastroenterol. Hepatol.8(3), 235–244 (2009).
   PubMed Web of Science ®Google Scholar
• Cameron AJ : Epidemiology of columnar-lined esophagus and adenocarcinoma.Gastroenterol. Clin. North Am.26(3), 487–494 (1997).
   PubMed Web of Science ®Google Scholar
• Rex DK , CummingsOW, ShawMet al. : Screening for Barrett‘s esophagus in colonoscopy patients with and without heartburn.Gastroenterology125(6), 1670–1677 (2003).
   PubMed Web of Science ®Google Scholar
• Veldhuyzen van Zanten SJ , ThomsonAB, BarkunANet al. : The prevalence of Barrett‘s oesophagus in a cohort of 1040 Canadian primary care patients with uninvestigated dyspepsia undergoing prompt endoscopy.Aliment Pharmacol. Ther.23(5), 595–599 (2006).
   PubMed Web of Science ®Google Scholar
• Ronkainen J , AroP, StorskrubbTet al. : Prevalence of Barrett‘s esophagus in the general population: an endoscopic study.Gastroenterology129(6), 1825–1831 (2005).
   PubMed Web of Science ®Google Scholar
• Gerson LB , ShetlerK, TriadafilopoulosG: Prevalence of Barrett‘s esophagus in asymptomatic individuals.Gastroenterology123(2), 461–467 (2002).
   PubMed Web of Science ®Google Scholar
• van Soest EM , DielemanJP, SiersemaPD, SturkenboomMC, KuipersEJ: Increasing incidence of Barrett‘s oesophagus in the general population.Gut54(8), 1062–1066 (2005).
   PubMed Web of Science ®Google Scholar
• Talley NJ , VakilN: Guidelines for the management of dyspepsia.Am. J. Gastroenterol.100(10), 2324–2337 (2005).
   PubMed Web of Science ®Google Scholar
• Winters C Jr, SpurlingTJ, ChobanianSJet al.: Barrett‘s esophagus. A prevalent, occult complication of gastroesophageal reflux disease.Gastroenterology92(1), 118–124 (1987).
   PubMed Web of Science ®Google Scholar
• Lagergren J , BergstromR, NyrenO: Association between body mass and adenocarcinoma of the esophagus and gastric cardia.Ann. Intern. Med.130(11), 883–890 (1999).
   PubMed Web of Science ®Google Scholar
• Lagergren J , BergstromR, LindgrenA, NyrenO: Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.N. Engl. J. Med.340(11), 825–831 (1999).
   PubMed Web of Science ®Google Scholar
• Anderson LA , WatsonRG, MurphySJet al. : Risk factors for Barrett‘s oesophagus and oesophageal adenocarcinoma: results from the FINBAR study.World J. Gastroenterol.13(10), 1585–1594 (2007).
   PubMed Web of Science ®Google Scholar
• Zagari RM , FuccioL, WallanderMAet al. : Gastro-oesophageal reflux symptoms, oesophagitis and Barrett‘s oesophagus in the general population: the Loiano–Monghidoro study.Gut57(10), 1354–1359 (2008).
   PubMed Web of Science ®Google Scholar
• Banki F , DemeesterSR, MasonRJet al. : Barrett‘s esophagus in females: a comparative analysis of risk factors in females and males.Am. J. Gastroenterol.100(3), 560–567 (2005).
   PubMed Web of Science ®Google Scholar
• Connor MJ , WestonAP, MayoMS, SharmaP: The prevalence of Barrett‘s esophagus and erosive esophagitis in patients undergoing upper endoscopy for dyspepsia in a VA population.Dig. Dis. Sci.49(6), 920–924 (2004).
   PubMed Web of Science ®Google Scholar
• Lin M , GersonLB, LascarR, DavilaM, TriadafilopoulosG: Features of gastroesophageal reflux disease in women.Am. J. Gastroenterol.99(8), 1442–1447 (2004).
   PubMed Web of Science ®Google Scholar
• Van Blankenstein M , LoomanCW, KruijshaarMEet al. : Modelling a population with Barrett‘s oesophagus from oesophageal adenocarcinoma incidence data.Scand. J. Gastroenterol.42(3), 308–317 (2007).
   PubMed Web of Science ®Google Scholar
• Cameron AJ , LomboyCT: Barrett‘s esophagus: age, prevalence, and extent of columnar epithelium.Gastroenterology103(4), 1241–1245 (1992).
   PubMed Web of Science ®Google Scholar
• Eloubeidi MA , ProvenzaleD: Clinical and demographic predictors of Barrett‘s esophagus among patients with gastroesophageal reflux disease: a multivariable analysis in veterans.J. Clin. Gastroenterol.33(4), 306–309 (2001).
   PubMed Web of Science ®Google Scholar
• Spechler SJ : Clinical practice. Barrett‘s Esophagus.N. Engl. J. Med.346(11), 836–842 (2002).
   PubMedGoogle Scholar
• Cook MB , GreenwoodDC, HardieLJ, WildCP, FormanD: A systematic review and meta-analysis of the risk of increasing adiposity on Barrett‘s esophagus.Am. J. Gastroenterol.103(2), 292–300 (2008).
   PubMed Web of Science ®Google Scholar
• Corley DA , KuboA, LevinTRet al. : Abdominal obesity and body mass index as risk factors for Barrett‘s esophagus.Gastroenterology133(1), 34–41 (2007).
   PubMed Web of Science ®Google Scholar
• Shaheen NJ , SharmaP, OverholtBFet al. : Radiofrequency ablation in Barrett‘s esophagus with dysplasia.N. Engl. J. Med.360(22), 2277–2288 (2009).
   PubMed Web of Science ®Google Scholar
• Pouw RE , WirthsK, EisendrathPet al. : Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett‘s esophagus with early neoplasia.Clin. Gastroenterol. Hepatol.8(1), 23–29 (2010).
   PubMed Web of Science ®Google Scholar
• Streitz JM Jr, Andrews CW Jr, Ellis FH Jr: Endoscopic surveillance of Barrett‘s esophagus. Does it help? J. Thorac. Cardiovasc. Surg.105(3), 383–387 (1993).
   PubMed Web of Science ®Google Scholar
• Gerson LB , EdsonR, LavoriPW, TriadafilopoulosG: Use of a simple symptom questionnaire to predict Barrett‘s esophagus in patients with symptoms of gastroesophageal reflux.Am. J. Gastroenterol.96(7), 2005–2012 (2001).
   PubMed Web of Science ®Google Scholar
• Locke GR , ZinsmeisterAR, TalleyNJ: Can symptoms predict endoscopic findings in GERD?Gastrointest. Endosc.58(5), 661–670 (2003).
   PubMed Web of Science ®Google Scholar
• Inadomi JM , SamplinerR, LagergrenJet al. : Screening and surveillance for Barrett esophagus in high-risk groups: a cost–utility analysis.Ann. Intern. Med.138(3), 176–186 (2003).
   PubMed Web of Science ®Google Scholar
• Soni A , SamplinerRE, SonnenbergA: Screening for high-grade dysplasia in gastroesophageal reflux disease: is it cost-effective?Am. J. Gastroenterol.95(8), 2086–2093 (2000).
   PubMed Web of Science ®Google Scholar
• Barbiere JM , LyratzopoulosG: Cost–effectiveness of endoscopic screening followed by surveillance for Barrett‘s esophagus: a review.Gastroenterology137(6), 1869–1876 (2009).
   PubMed Web of Science ®Google Scholar
• Dumortier J , NapoleonB, HedeliusFet al. : Unsedated transnasal EGD in daily practice: results with 1100 consecutive patients.Gastrointest. Endosc.57(2), 198–204 (2003).
   PubMed Web of Science ®Google Scholar
• Craig A , HanlonJ, DentJ, SchoemanM: A comparison of transnasal and transoral endoscopy with small-diameter endoscopes in unsedated patients.Gastrointest. Endosc.49(3 Pt 1), 292–296 (1999).
   PubMed Web of Science ®Google Scholar
• Trevisani L , CifalaV, SartoriSet al. : Unsedated ultrathin upper endoscopy is better than conventional endoscopy in routine outpatient gastroenterology practice: a randomized trial.World J. Gastroenterol.13(6), 906–911 (2007).
   PubMed Web of Science ®Google Scholar
• Eliakim R , YassinK, ShlomiI, SuissaA, EisenGM: A novel diagnostic tool for detecting oesophageal pathology: the PillCam oesophageal video capsule.Aliment Pharmacol. Ther.20(10), 1083–1089 (2004).
   PubMed Web of Science ®Google Scholar
• Lin OS , SchembreDB, MergenerKet al. : Blinded comparison of esophageal capsule endoscopy versus conventional endoscopy for a diagnosis of Barrett‘s esophagus in patients with chronic gastroesophageal reflux.Gastrointest. Endosc.65(4), 577–583 (2007).
   PubMed Web of Science ®Google Scholar
• Ramirez FC , AkinsR, ShaukatM: Screening of Barrett‘s esophagus with string-capsule endoscopy: a prospective blinded study of 100 consecutive patients using histology as the criterion standard.Gastrointest. Endosc.68(1), 25–31 (2008).
   PubMed Web of Science ®Google Scholar
• Falk GW , ChittajalluR, GoldblumJRet al. : Surveillance of patients with Barrett‘s esophagus for dysplasia and cancer with balloon cytology.Gastroenterology112(6), 1787–1797 (1997).
   PubMed Web of Science ®Google Scholar
• Saad RS , MahoodLK, ClaryKMet al. : Role of cytology in the diagnosis of Barrett‘s esophagus and associated neoplasia.Diagn. Cytopathol.29(3), 130–135 (2003).
   PubMed Web of Science ®Google Scholar
• Hardwick RH , MorganRJ, WarrenBF, LottM, AldersonD: Brush cytology in the diagnosis of neoplasia in Barrett‘s esophagus.Dis. Esophagus10(4), 233–237 (1997).
   PubMedGoogle Scholar
• Lao-Sirieix P , RousB, O‘DonovanMet al. : Non-endoscopic immunocytological screening test for Barrett‘s oesophagus.Gut56(7), 1033–1034 (2007).
   PubMed Web of Science ®Google Scholar
• Rygiel AM , MilanoF, Ten Kate FJ et al.: Assessment of chromosomal gains as compared to DNA content changes is more useful to detect dysplasia in Barrett‘s esophagus brush cytology specimens. Genes Chromosomes Cancer47(5), 396–404 (2008).
   PubMed Web of Science ®Google Scholar
• Lao-Sirieix P , LovatL, FitzgeraldRC: Cyclin A immunocytology as a risk stratification tool for Barrett‘s esophagus surveillance.Clin. Cancer Res.13(2 Pt 1), 659–665 (2007).
   PubMed Web of Science ®Google Scholar
• Fahmy M , SkacelM, GramlichTLet al. : Chromosomal gains and genomic loss of p53 and p16 genes in Barrett‘s esophagus detected by fluorescence in situ hybridization of cytology specimens.Mod. Pathol.17(5), 588–596 (2004).
   PubMed Web of Science ®Google Scholar
• Rygiel AM , van Baal JW, Milano F et al.: Efficient automated assessment of genetic abnormalities detected by fluorescence in situ hybridization on brush cytology in a Barrett esophagus surveillance population. Cancer109(10), 1980–1988 (2007).
   PubMed Web of Science ®Google Scholar
• MacLennan AJ , OrringerMB, BeerDG: Identification of intestinal-type Barrett‘s metaplasia by using the intestine-specific protein villin and esophageal brush cytology.Mol. Carcinog.24(2), 137–143 (1999).
   PubMed Web of Science ®Google Scholar
• Lao-Sirieix P , BoussioutasA, KadriSRet al. : Non-endoscopic screening biomarkers for Barrett‘s oesophagus: from microarray analysis to the clinic.Gut58(11), 1451–1459 (2009).
   PubMed Web of Science ®Google Scholar
• Kadri SR , Lao-SirieixP, O‘DonovanMet al. : Acceptability and accuracy of a non-endoscopic screening test for Barrett‘s oesophagus in primary care: cohort study.BMJ341c4372 (2010).
   Google Scholar
• Bunting PS : Screening for prostate cancer with prostate-specific antigen: beware the biases.Clin. Chim. Acta315(1–2), 71–97 (2002).
   PubMed Web of Science ®Google Scholar
• Towler B , IrwigL, GlasziouPet al. : A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult.BMJ317(7158), 559–565 (1998).
   PubMedGoogle Scholar
• Nanda K , McCroryDC, MyersERet al. : Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review.Ann. Intern. Med.132(10), 810–819 (2000).
   PubMed Web of Science ®Google Scholar
• Prach AT , MacDonaldTA, HopwoodDA, JohnstonDA: Increasing incidence of Barrett‘s oesophagus: education, enthusiasm, or epidemiology?Lancet350(9082), 933 (1997).
   PubMed Web of Science ®Google Scholar
• Conio M , CameronAJ, RomeroYet al. : Secular trends in the epidemiology and outcome of Barrett‘s oesophagus in Olmsted County, Minnesota.Gut48(3), 304–309 (2001).
   PubMed Web of Science ®Google Scholar

▪ Websites

• NHS: Criteria for appraising the viability, effectiveness and appropriateness of a screening program www.screening.nhs.uk/criteria
   Google Scholar
• NICE: Dyspepsia: Managing dyspepsia in adults in primary care www.nice.org.uk/guidance/cg17
   Google Scholar
• Donaldson L: On the state of public health: Annual Report of the Chief Medical Officer 2007 www.dh.gov.uk/en/Publicationsandstatistics/Publications/AnnualReports/DH_086176 (Accessed 20January2009)
   Google Scholar